The role of citrullinated protein antibodies in predicting erosive disease in rheumatoid arthritis: A systematic literature review and meta-analysis

International Journal of Rheumatology

Volumn 2015, Issue , 2015, Pages

  Jilani, A A ^a   Mackworth Young, C G ^b  

^a CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHIMERIC FIBRIN FILAGGRIN CITRULLINATED PEPTIDE 1 ANTIBODY; CITRULLINATED ENOLASE PEPTIDE 1 ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; MUTATED CITRULLINATED VIMENTIN ANTIBODY; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

BONE RADIOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; DISEASE SEVERITY; ECHOGRAPHY; HUMAN; JOINT DESTRUCTION; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

EID: 84925438428     PISSN: 16879260     EISSN: 16879279     Source Type: Journal    
DOI: 10.1155/2015/728610     Document Type: Review

References (42)

1. D. L. Scott, "Radiological progression in established rheumatoid arthritis, " The Journal of Rheumatology, vol. 31, supplement 69, pp. 55-65, 2004.
2. D. van der Woude, S. Rantapaa-Dahlqvist, A. Ioan-Facsinay et al. , "Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis, " Annals of the Rheumatic Diseases, vol. 69, no. 8, pp. 1554-1561, 2010.
3. N. Wegner, K. Lundberg, A. Kinloch et al. , "Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis, " Immunological Reviews, vol. 233, no. 1, pp. 34-54, 2010.
4. N. Bizzaro, "Antibodies to citrullinated peptides: a significant step forward in the early diagnosis of rheumatoid arthritis, " Clinical Chemistry and Laboratory Medicine, vol. 45, no. 2, pp. 150-157, 2007.
5. E. R. Vossenaar, A. J. W. Zendman, W. J. vanVenrooij, andG. J. M. Pruijn, "PAD, a growing family of citrullinating enzymes: Genes, features and involvement in disease, " BioEssays, vol. 25, no. 11, pp. 1106-1118, 2003.
6. D. Makrygiannakis, E. Af Klint, I. E. Lundberg et al. , "Citrullination is an inflammation-dependent process, " Annals of the Rheumatic Diseases, vol. 65, no. 9, pp. 1219-1222, 2006.
7. M. Nakayama-Hamada, A. Suzuku, and K. Kubota, "Comparison of enzymatic properties between hPAD12 and hPAD14, " Biochemical and Biophysical Research Communications, vol. 327, pp. 192-200, 2005.
8. E. R. Vossenaar, T. J. M. Smeets, M. C. Kraan, J. M. Raats, W. J. van Venrooij, and P. P. Tak, "The presence of citrullinated proteins is not specific for rheumatoid synovial tissue, " Arthritis and Rheumatism, vol. 50, no. 11, pp. 3485-3494, 2004.
9. H. Bang, K. Egerer, A. Gauliard et al. , "Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis, " Arthritis and Rheumatism, vol. 56, no. 8, pp. 2503-2511, 2007.
10. L. Innala, H. Kokkonen, C. Eriksson, E. Jidell, E. Berglin, and S. Rantapaa-Dahlqvist, "Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides, " Journal of Rheumatology, vol. 35, no. 6, pp. 1002-1008, 2008.
11. F. C. Arnett, S. M. Edworthy, D. A. Bloch et al. , "The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, " Arthritis and Rheumatism, vol. 31, no. 3, pp. 315-324, 1988.
12. M. W. Ropes, G. A. Bennett, S. Cobb et al. , "Diagnostic criteria for rheumatoid arthritis 1958 revision, " Annals of the Rheumatic Diseases, vol. 18, no. 1, pp. 49-53, 1959.
13. D. van der Heijde, "How to read radiographs according to the Sharp/van der Heijde method, " Journal of Rheumatology, vol. 26, no. 3, pp. 743-745, 1999.
14. A. Larsen, "How to apply larsen score in evaluating radiographs of rheumatoid arthritis in longterm studies?" Journal of Rheumatology, vol. 22, no. 10, pp. 1974-1975, 1995.
15. E. M. Dias, C. Lukas, R. Landewe, S. Fatenejad, and D. Van Der Heijde, "Reliability and sensitivity to change of the Simple Erosion Narrowing Score compared with the Sharp-van der Heijde method for scoring radiographs in rheumatoid arthritis, " Annals of the Rheumatic Diseases, vol. 67, no. 3, pp. 375-379, 2008.
16. J. A. Hayden, P. Cote, and C. Bombardier, "Evaluation of the quality of prognosis studies in systematic reviews, " Annals of Internal Medicine, vol. 144, no. 6, pp. 427-437, 2006.
17. K. P. Machold, T. A. Stamm, V. P. K. Nell et al. , "Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease, " Rheumatology, vol. 46, no. 2, pp. 342-349, 2007.
18. M. Bukhari, W. Thomson, H. Naseem et al. , "The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register, " Arthritis and Rheumatism, vol. 56, no. 9, pp. 2929-2935, 2007.
19. S. Kaltenhauser, M. Pierer, S. Arnold et al. , "Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis, " Rheumatology, vol. 46, no. 1, pp. 100-104, 2007.
20. A. Rojas-Villarraga, F. J. Diaz, E. Calvo-Paramo et al. , "Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis, " Journal of Autoimmunity, vol. 32, no. 1, pp. 64-69, 2009.
21. S. W. Syversen, G. L. Goll, D. van derHeijde et al. , "Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study, " Annals of the Rheumatic Diseases, vol. 69, no. 2, pp. 345-351, 2010.
22. L. Mathsson, M. Mullazehi, M. C. Wick et al. , "Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides, " Arthritis and Rheumatism, vol. 58, no. 1, pp. 36-45, 2008.
23. B. A. Fisher, D. Plant, M. Brode et al. , "Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis, " Annals of the Rheumatic Diseases, vol. 70, no. 6, pp. 1095-1098, 2011.
24. H. E. Mansour, K. M. Metwaly, I. A. Hassan, H.-A. A. Elshamy, and M. M. S. Elbeblawy, "Antibodies to mutated citrullinated vimentin in rheumatoid arthritis: diagnostic value, association with radiological damage and axial skeleton affection, " Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, vol. 3, pp. 33-42, 2010.
25. M. L. Hetland, K. Stengaard-Pedersen, P. Junker et al. , "Radiographic progression and remission rates in early rheumatoid arthritis-MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the doubleblind randomised CIMESTRA trial, " Annals of the Rheumatic Diseases, vol. 69, no. 10, pp. 1789-1795, 2010.
26. D. Plant and W. Thomson, "The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis, " Rheumatology, vol. 10, pp. 1093-1100, 2010.
27. H. H. Kim, J. Kim, S.-H. Park, S.-K. Kim, O.-D. Kim, and J.-Y. Choe, "Correlation of anti-cyclic citrullinated antibody with hand joint erosion score in rheumatoid arthritis patients, " Korean Journal of Internal Medicine, vol. 25, no. 2, pp. 201-206, 2010.
28. R. Sanmarti, E. Graell, M. L. Perez et al. , "Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis, " Arthritis Research andTherapy, vol. 11, no. 5, article R135, 2009.
29. M. P. M. van der Linden, D. van der Woude, A. Ioan-Facsinay et al. , "Value of anti-modified citrullinated vimentin and thirdgeneration anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis, " Arthritis and Rheumatism, vol. 60, no. 8, pp. 2232-2241, 2009.
30. S. Reneses, M. F. Gonzalez-Escribano, A. Fernandez-Suarez et al. , "The value of HLA-DRB1 shared epitope,-308 tumor necrosis factor-α gene promoter polymorphism, rheumatoid factor, anti-citrullinated peptide antibodies, and early erosions for predicting radiological outcome in recent-onset rheumatoid arthritis, " Journal of Rheumatology, vol. 36, no. 6, pp. 1143-1149, 2009.
31. N. Courvoisier, M. Dougados, A. Cantagrel et al. , "Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study, " Arthritis Research and Therapy, vol. 10, article R106, 2008.
32. E. W. Karlson, L. B. Chibnik, J. Cui et al. , "Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study, " Annals of the Rheumatic Diseases, vol. 67, no. 3, pp. 358-363, 2008.
33. D. Mewar, A. Coote, D. J. Moore et al. , "Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis, " Arthritis Research and Therapy, vol. 8, no. 4, article R128, 2006.
34. O. Meyer and P. Nicaise-Roland, "Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis, " Arthritis Research and Therapy, vol. 40, pp. 1186-1196, 2006.
35. G. Boire, P. Cossette, A. J. de Brum-Fernandes et al. , "Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis, " Arthritis Research and Therapy, vol. 7, no. 3, pp. R592-R603, 2005.
36. S. M. Bongi, R. Manetti, D. Melchiorre et al. , "Anti-cyclic citrullinated peptide antibodies are highly associated with severe bone lesions in rheumatoid arthritis anti-CCP and bone damage in RA, " Autoimmunity, vol. 37, no. 6-7, pp. 495-501, 2004.
37. E. Lindqvist, K. Eberhardt, K. Bendtzen, D. Heinegard, and T. Saxne, "Prognostic laboratorymarkers of joint damage in rheumatoid arthritis, " Annals of the Rheumatic Diseases, vol. 64, no. 2, pp. 196-201, 2005.
38. L. M. A. Jansen, D. van Schaardenburg, I. E. van der Horst-Bruinsma, R. J. van de Stadt, M. H. M. T. de Koning, and B. A. C. Dijkmans, "The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritis, " Journal of Rheumatology, vol. 30, no. 8, pp. 1691-1695, 2003.
39. H. Orbach, B. Gilburd, C. M. Brickman, R. Gerli, and Y. Shoenfeld, "Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis and predictor of an erosive disease, " Israel Medical Association Journal, vol. 4, no. 11, pp. 892-893, 2002.
40. J. Vencovsk?, S. Machacek, L. Sedova? et al. , "Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis, " Annals of the Rheumatic Diseases, vol. 62, no. 5, pp. 427-430, 2003.
41. A. Baillet, C. Gaujoux-Viala, G. Mouterde et al. , "Comparisonof the efficacy of sonography, magnetic resonance imaging and conventional radiography for the detection of bone erosions in rheumatoid arthritis patients: a systematic review and metaanalysis, " Rheumatology (Oxford, England), vol. 50, no. 6, pp. 1137-1147, 2011.
42. X. Jiang, L. A. Trouw, D. van derWoude et al. , "Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies, " Annals of the Rheumatic Diseases, vol. 73, no. 10, pp. 1761-1768, 2014.